India’s Heart Health Crisis Is Moving Into Younger Age Groups
Cardiovascular risk is increasingly appearing in Indians in their 30s and 40s, with experts highlighting lifestyle, metabolic and genetic factors alongside advances in cardiac treatment.
Category
Cardiovascular risk is increasingly appearing in Indians in their 30s and 40s, with experts highlighting lifestyle, metabolic and genetic factors alongside advances in cardiac treatment.
Homoeopathy in India is seeing a shift toward digital consultations, structured case documentation and outcome tracking, as practitioners call for stronger research, regulation and standardisation.
India's digital health infrastructure is expanding rapidly, but the next healthcare leap may depend on patient control over data, interoperability and accountable AI.
Explore the genetics, nutrition, antibiotic concerns and food-safety factors behind the rapid growth of modern broiler chickens.
Robotic-assisted knee replacement is bringing greater precision and personalisation to joint replacement, while helping surgeons preserve bone and soft tissue and potentially support faster recovery.
From managing nausea to preventing nutritional deficiencies, experts explain what expecting mothers should eat, avoid and prioritise during the first trimester.
India’s food-safety challenges are moving beyond adulteration, with microbial contamination, temperature abuse, traceability, labelling and supply-chain risks emerging as critical concerns.
Delayed parenthood, changing career priorities, sedentary lifestyles, stress and metabolic health are reshaping India's fertility landscape, raising questions about reproductive health and timely care.
Artificial intelligence is transforming healthcare by enabling earlier disease detection, improving clinical decision-making, streamlining hospital operations and supporting a more predictive, patient-centric model of care.
DeepFacts Pvt. Ltd. has announced plans to expand its AI-powered remote patient monitoring platform, proRITHM, across southern India before targeting nationwide growth by early 2027 and a U.S. market entry by late 2027 or early 2028.
Zydus Lifesciences has received approval to initiate a Phase III clinical trial of Desidustat for sickle cell disease in collaboration with ICMR, following encouraging Phase II results demonstrating efficacy and safety.
CBM India has brought together LGBTQIA+ community representatives, government officials and civil society organisations in Bengaluru to co-create Project Sparsh, an initiative aimed at improving health, livelihoods and social inclusion.